Curative Biotechnology, Inc. (CUBT)

Curative Biotechnology Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2022	2021	2020
Debt / Equity Ratio	-	-0.05	-	-0.12
Debt / EBITDA Ratio	-	-0.24	-	-0.12
Debt / FCF Ratio	-	-0.66	-	-2.49
Quick Ratio	-	0.01	0.95	0.35
Interest Coverage	-	-3.79	-28.29	-133.38
Return on Equity (ROE)	-	27.30%	32.64%	103.29%
Return on Assets (ROA)	-	-268.28%	-221.39%	-205.37%
Return on Capital (ROIC)	-	22.79%	30.54%	116.20%
Buyback Yield / Dilution	-16848.72%	-16848.72%	0.80%	-